Revolutionary gene therapies to treat motor neuron disease
A new spin-off company of MQ University
Celosia Therapeutics
Celosia Therapeutics is a privately held pre-clinical stage gene therapy company, developing solutions for neurodegenerative diseases that have limited alternative therapeutic options.
Celosia aims to address unmet therapeutic needs in neurodegenerative diseases.
Learn more about Celosia here.